Durlip™ Vitamin C: The Liposomal Vitamin C That Sets a New Standard in Bioavailability
Jul 01,2026
多行文本内容元素
富文本内容绑定数据后可解析HTML语言内容
INNOBIO's advanced liposomal technology is redefining vitamin C supplementation with science-backed absorption, enhanced stability, and superior formulation flexibility.
The global dietary supplement market is witnessing a paradigm shift as consumers increasingly demand nutrients that are not just present, but truly effective. At the forefront of this movement is Durlip™ Liposomal Vitamin C from INNOBIO, a next-generation ingredient designed to overcome the significant challenge of poor nutrient bioavailability .
The Bioavailability Bottleneck
Traditional vitamin C, a water-soluble nutrient, relies on saturable sodium-dependent transporters (SVCT1) for absorption in the small intestine. This pathway is easily overwhelmed, leading to a non-linear relationship between dosage and absorption. As intake increases, absorption efficiency drops, and excess vitamin C is simply excreted . This results in a classic problem for manufacturers and consumers alike: high doses that fail to translate into high plasma levels.
The Durlip™ Difference: Science-Driven Delivery
Durlip™ Liposomal Vitamin C solves this problem by encapsulating ascorbic acid within a phospholipid bilayer, creating a spherical nanocarrier . This structure mimics a fat-soluble nutrient, allowing it to bypass the saturation-limited transport systems of the gut. Instead, the liposomes are absorbed through alternative pathways, including endocytosis and fusion with cell membranes, delivering the active compound more efficiently into the bloodstream and cells .
Proven Superior Pharmacokinetics
The enhanced bioavailability of Durlip™ Liposomal Vitamin C is not just a theoretical claim; it is supported by comparative bioavailability studies.
AUC (Area Under the Curve) Increased by 388%: This metric represents the total absorption of vitamin C over time, demonstrating significantly greater overall delivery compared to standard non-liposomal vitamin C .
Cmax (Peak Plasma Concentration) Increased by 441%: This indicates a much higher peak concentration of vitamin C in the blood, showing that more of the nutrient reaches systemic circulation .

Durlip™ Liposomal Vitamin C combines a uniform particle size of 218 nm with excellent cold‑water dispersibility and flowability, ensuring smooth processing and stable dispersion without sedimentation or aggregation even at 40 °C and across a wide concentration range.
Versatile Applications for Global Brands
Durlip™ Liposomal Vitamin C offers formulators the flexibility to create consumer-friendly products. It is suitable for use in :
Tablets: For a classic, familiar delivery method.
Hard Capsules: Offering precise, on-the-go dosing.
Powdered Beverages: Enabling the creation of delicious, drinkable supplements.
Functional Foods: Opening up new possibilities in the food sector.
With the global liposomal dietary supplement market projected to reach new heights , INNOBIO’s Durlip™ technology is poised to help brands lead the market with innovative, high-performance nutrition products.
PREVIOUS:
Related Information
Liposomal Vitamin C manufacturer
Why Durlip™ Liposomal Vitamin C stands out